Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 454 across all filing types
Latest filing 2021-10-14 AGM Information
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting 36 pages 2.3MB
AGM Information Classification · 100% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' and includes detailed information about the upcoming AGM, including the date, time, virtual meeting link, agenda items, and resolutions to be voted on. It references the Annual Report for the financial year ended 30 June 2021 but does not contain the report itself. The document also includes an Explanatory Memorandum and Proxy Form, which are typical components of AGM notices. The content focuses on informing shareholders about the meeting and the voting process rather than presenting financial data or results. Therefore, this document is a notice and materials related to the Annual General Meeting, not the Annual Report or other filings.
2021-10-14 English
Letter to Shareholders regarding Annual General Meeting 2 pages 174.3KB
AGM Information Classification · 100% confidence The document is a notice to shareholders about the Annual General Meeting (AGM) of Little Green Pharma Ltd, including details on the meeting date, virtual participation, proxy voting instructions, and how to access the Notice of Meeting electronically. It does not contain financial statements, management discussion, or results, but rather logistical and procedural information related to the AGM. The document length is 3821 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2021-10-14 English
Appendix 4G and Corporate Governance Statement 30 pages 3.5MB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a form used by Australian listed entities to confirm compliance with corporate governance disclosure requirements. The document includes a checklist of governance principles and recommendations, indicating whether the entity has followed them and where disclosures can be found (e.g., in the corporate governance statement on the website). It explicitly states that Appendix 4G is not a substitute for the corporate governance statement but serves as a verification tool. The document is not a full annual report, audit report, or management report but a regulatory filing to comply with ASX listing rules. It does not contain financial statements or detailed financial analysis but governance compliance information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous compliance documents that do not fit other specific categories.
2021-09-28 English
Annual Report to shareholders 37 pages 3.1MB
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT YEAR ENDED 30 JUNE 2021' and contains detailed sections typical of an annual report, including Chairman's Letter, Managing Director's Message, Strategy, Capability, Directors' Report, Independent Auditor's Report, and Financial Report. It covers the full fiscal year ending June 30, 2021, and includes comprehensive corporate information, operational updates, financial performance, and strategic outlook. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2021
2021-09-28 English
Change of Director's Interest Notice x 2 4 pages 232.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by company directors, including number of shares held before and after the change, nature of the interest, and dates of changes. There is no financial performance data, earnings information, or management discussion. The document is a formal notification of personal share transactions by company directors, which fits the definition of Director's Dealing filings. The document length (8000 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive report of insider trades.
2021-09-07 English
LGP expands into Psychedelic Medicines 3 pages 373.5KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 7 September 2021 from Little Green Pharma regarding the expansion into psychedelic medicines, specifically the granting of a Schedule 9 licence to supply psilocybin. It includes details about the company's strategy, appointments, and plans for clinical trials. There are no financial statements, quarterly or annual results, or detailed financial data. The document is a corporate announcement about a business development and regulatory approval rather than a financial report or management discussion. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a regulatory filing or certification letter either. The content is best classified as a Capital/Financing Update (CAP) because it relates to a significant business expansion and strategic development involving licensing and operational plans, which are typical of capital or financing updates in corporate announcements.
2021-09-06 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.